Search results
Showing 3001 to 3050 of 3765 results for treatment
include heterogeneous groups of patients. Potential benefits of successful treatment in cerebral disease may include the avoidance of...
study would also inform cost-effectiveness analyses for the prevention and treatment of delirium. Source guidance details Comes from...
This quality standard covers diagnosing and managing drug allergy in adults, young people and children. It describes high-quality care in priority areas for improvement.
View quality statements for QS97Show all sections
Sections for QS97
- Quality statements
- Quality statement 1: Documentation using the structured assessment guide
- Quality statement 2: Advice about carrying personal structured drug information
- Quality statement 3: Referral to specialist drug allergy services
- Quality statement 4: Recording drug allergy status in electronic medical records
- Quality statement 5: Updating information on drug allergy status
- Quality statement 6 (developmental): Prescription information on drug avoidance
- About this quality standard
Dr Sam Roberts, chief executive at NICE, looks back at NICE's achievements over the past year and discusses our priorities for 2023.
interventions (for example, mode of delivery, duration, content, and intensity of treatment) that are needed for use in pregnancy - the...
This guidance has been updated and replaced by NICE technology appraisal guidance 426.
This guidance has been updated and replaced by NICE technology appraisal guidance 684.
In development Reference number: GID-TA11697 Expected publication date: TBC
In development Reference number: GID-TA11589 Expected publication date: TBC
Evidence-based recommendations on SecurAcath for securing percutaneous catheters.
This guideline covers how to increase uptake of the free flu vaccination among people who are eligible. It describes ways to increase awareness and how to use all opportunities in primary and secondary care to identify people who should be encouraged to have the vaccination.
disorder may present problems for engagement even in those motivated to seek treatment. Structured clinical management is a...
the outcomes and duration of these outcomes are similar to the initial treatment. If repeated radiofrequency denervation is to be...
This guidance has been updated and replaced by NICE technology appraisal guidance 473.
However, there is clear evidence of poor engagement, uptake and retention in treatment for people with mental health problems in contact...
to confirm or refute this. Better evidence may improve diagnostic and treatment decisions. Source guidance details Comes from guidance
Servo-n with Neurally Adjusted Ventilatory Assist (NAVA) for babies and children (MIB163)
NICE has developed a medtech innovation briefing (MIB) on Serve-n with Neurally Adjusted Ventilatory Assist (NAVA) for babies and children .
details Comes from guidance Eating disorders: recognition and treatment Number NG69 Date issued May 2017 Other details
oral contraceptives are often prescribed when this might not be the best treatment in terms of quality of life and preservation of bone...
identified and addressed at an early stage, yet people often delay seeking treatment for up to 10 years. There are certain groups who...
methods of prevention. Pharmacological agents may be a simple preventive treatment for delirium, but there is uncertainty about...
autistic children and young people and an anxiety disorder. Pharmacological treatment should be with a selective serotonin reuptake...
surgeries and health clinics, reduced need for unnecessary medications and treatment, improved health for the whole family and improved...
In development Reference number: GID-TA11165 Expected publication date: TBC
This guideline covers the planning, delivery and review of social work interventions for adults who have complex needs. It promotes ways for social work professionals, other care staff and people with complex needs to work together to make decisions about care and support.
people, or physical infrastructure may need to be built to administer treatments. These implementation costs could be very high,...
This guidance has been updated and replaced by NICE technology appraisal guidance 946.
In development Reference number: GID-TA11486 Expected publication date: TBC
BladderScan BVI 9400 3D portable ultrasound scanner for measuring bladder volume (MIB50)
NICE has developed a medtech innovation briefing (MIB) on the BladderScan BVI 9400 3D portable ultrasound scanner for measuring bladder volume
reducing the long-term physical health risks associated with antipsychotic treatment and improving outcomes. The programme of research...
avoiding the need to consider this at a future date. For example, initial treatment by wide local excision often necessitates...
prolonged pattern of intrusive procedures that dominate investigation, treatment and follow-up regimens for bladder cancer may also...
This interim statement outlines early value assessments, a new evidence-based approach designed to improve the care of people and effective use of NHS resources through quicker access to promising health technologies that address national unmet need
antiviral-monoclonal antibodies C:• standard care without the combination treatment O:• effectiveness outcomes • COVID-19 related...
Percutaneous interlaminar endoscopic lumbar discectomy for sciatica (IPG555)
Evidence-based recommendations on percutaneous interlaminar endoscopic lumbar discectomy for sciatica in adults. This involves removing part of the damaged spinal disc to relieve the symptoms of sciatica.
View recommendations for IPG555Show all sections
and follow-up efficacy (including symptom relief), need for subsequent treatments, quality of life and safety outcomes for at least 1...
Evidence-based recommendations on ClearGuard HD antimicrobial barrier caps for preventing haemodialysis catheter-related bloodstream infections.
Subscribe to NICE newsletters and alerts for the latest healthcare guidance, clinical updates, and evidence-based resources across health and social care.
Subscribe to NICE newsletters and alerts for the latest healthcare guidance, clinical updates, and evidence-based resources across health and social care.
Falls: assessment and prevention in older people and in people 50 and over at higher risk (NG249)
This guideline covers assessing risk of falling and interventions to prevent falls in all people aged 65 and over, and people aged 50 to 64 who are at higher risk of falls. It aims to reduce the risk and incidence of falls, and the associated distress, pain, injury, loss of confidence, loss of independence and mortality.
should have both cardiac and vascular surgical support for the emergency treatment of complications and subsequent patient care. NICE...
example, people with multimorbidity who find it difficult to manage their treatment or care or day-to-day activities, people with...
This guidance has been updated and replaced by NICE guideline CG175.
This guidance has been updated and replaced by the NICE guideline on asthma: diagnosis, monitoring and chronic asthma management (BTS, NICE, SIGN).
Discontinued Reference number: GID-TAG479
Dupilumab for children with severe atopic dermatitis [TSID10434]
Topic prioritisation
Magtrace and Sentimag system for locating sentinel lymph nodes for breast cancer (HTG642)
Evidence-based recommendations on Magtrace and Sentimag system for locating sentinel lymph nodes for breast cancer.
Discontinued Reference number: GID-TA11255
We have moved medical technologies guidance 9 to become HealthTech guidance 282. This is to better reflect the NICE HealthTech programme which combines the former NICE Diagnostics Assessment programme, Interventional Procedures programme and Medical Technologies Evaluation programme and to help you find relevant content more quickly. The guidance itself has not changed.